Related Experiment Video
Updated: Jun 5, 2026
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Antithrombotic and anticoagulation therapy after stroke and transient ischemic attacks]
1Neurologische Universitätsklinik Essen, Hufelandstraße 55, 45122, Essen.
Der Nervenarzt
|December 25, 2010
Summary
Platelet inhibitors and anticoagulants help prevent recurrent strokes. New anticoagulants like dabigatran show promise, reducing stroke risk and bleeding compared to warfarin.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Context:
- Patients with transient ischemic attack (TIA) or ischemic stroke face a high risk of recurrent stroke.
- Atrial fibrillation significantly increases stroke risk (five-fold).
- Current treatments include platelet inhibitors (aspirin, aspirin/dipyridamole, clopidogrel) and oral anticoagulants.
Purpose:
- To review stroke prevention strategies, including antiplatelet therapy and anticoagulation.
- To discuss the efficacy and safety of novel anticoagulants compared to traditional vitamin K antagonists.
Summary:
- Platelet inhibitors are effective for secondary stroke prevention, with aspirin for low-risk patients and combination therapy for higher-risk individuals.
- Oral anticoagulation dramatically reduces stroke risk in atrial fibrillation patients.
- Newer anticoagulants, such as dabigatran (a direct thrombin inhibitor), offer comparable or superior efficacy to warfarin with a significant reduction in bleeding events.
Impact:
- Improved secondary stroke prevention strategies.
- Enhanced patient safety through reduced bleeding risks with novel anticoagulants.
- Potential for wider adoption of effective anticoagulation in atrial fibrillation management.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...